 AFP | Generics and Job-Cutting Costs Lower Drug Makers’ Profits New York Times, United States - The results included $113 million in charges as the company cut jobs, shut plants and shed products to deliver $1.5 billion in annual savings before 2012. ... AstraZeneca, Bristol-Myers, Bayer Earnings Decline (Update1) UPDATE 3-Bristol profit slips on charges; drug sales soar Bristol-Myers's Net Falls 4.2% As Generic Competition Looms |
Friday, April 25, 2008
Generics and Job-Cutting Costs Lower Drug Makers’ Profits - New York Times
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment